Me will hold a second auction for its DNA data with an opening bid of $305 million from former CEO Anne Wojcicki. Here's all ...

Nucleus Genomics launches IVF software that analyzes embryos for genetic risks and traits to aid parental choices.

Researchers have developed a blood test capable of rapidly diagnosing rare genetic diseases in babies and children, ...

Once a Silicon Valley pioneer in consumer genetic testing, 23andMe is now at the center of a high-stakes legal and financial ...

Take a fascinating look back at the science and technology advances that shaped medicine’s past and will define its future.

Caitlin Cronan wasn't going to have children if it meant passing along her kidney disease. Thankfully, her diagnosis wasn't the end of her motherhood journey.

Western Sydney University researchers have led a global team to pioneer a new AI-powered tool to assess the risk of ...

Before welcoming a new life, ensure a healthy start! Discover why thalassemia screening is a crucial step in family planning, ...

A single vial of blood could help tell you which drugs to take, foods to eat, and more.

"The decision to exclude Imane is not ours. We regret it." This was the blunt statement made by Dirk Renders, director of communications for the Eindhoven Box Cup in the Netherland ...

Nucleus Genomics unveiled a $5,999 service Wednesday allowing prospective parents to rank embryos created during in vitro ...

Roughly 55 people on Guam are diagnosed with a bleeding disorder, but as the National Bleeding Disorder Foundation stressed, ...